Axa S.A. Autolus Therapeutics PLC Transaction History
Axa S.A.
- $29.5 Billion
- Q1 2025
A detailed history of Axa S.A. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Axa S.A. holds 3,126,167 shares of AUTL stock, worth $6.38 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,126,167
Previous 1,824,685
71.33%
Holding current value
$6.38 Million
Previous $4.29 Million
12.99%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
99Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$55.3 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$41.8 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$36.4 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$33.9 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$22.4 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $185M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...